Fei Kang
- Molecular Biology top 10%
- Cancer Research top 5%
- Biomedical Engineering top 10%
- Oncology top 10%
- Rheumatology top 5%
- Topics
- Bone Metabolism and Diseases (17 papers)Cancer-related molecular mechanisms research (10 papers)Bone health and treatments (9 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Fei Kang
47 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 1.0k
- Cancer Research 563
- Biomedical Engineering 341
- Oncology 277
- Rheumatology 247
Countries citing papers authored by Fei Kang
This map shows the geographic impact of Fei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Kang more than expected).
Fields of papers citing papers by Fei Kang
This network shows the impact of papers produced by Fei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Kang. The network helps show where Fei Kang may publish in the future.
Co-authorship network of co-authors of Fei Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Kang. A scholar is included among the top collaborators of Fei Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Kang. Fei Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 3 | |
| 7 | 40 | |
| 8 | 11 | |
| 9 | 26 | |
| 10 | 75 | |
| 11 | 43 | |
| 12 | 34 | |
| 13 | 29 | |
| 14 | 13 | |
| 15 | 158 | |
| 16 | 46 | |
| 17 | 31 | |
| 18 | 78 | |
| 19 | 12 | |
| 20 | 110 |
About Fei Kang
Fei Kang is a scholar working on Cancer Research, Rheumatology and Orthopedics and Sports Medicine, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (17 papers), Cancer-related molecular mechanisms research (10 papers) and Bone health and treatments (9 papers). The work is most often cited by research in Cancer Research (563 citations), Orthopedics and Sports Medicine (143 citations) and Rheumatology (247 citations). Fei Kang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Shiwu Dong, Ce Dou, Jian‐Mei Li, Zhen Cao, Yun Bai, Xiaochao Yang, Jianzhong Xu, Ning Ding, Bo Yang and Hong Jiang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.